News | MRI Breast | February 07, 2017

New Breast MRI Protocol Improves Cancer Detection in Women with Dense Breasts

Technique reduces breast MRI down to essential components that can be performed more quickly and affordably

breast MRI, new AB-MR exam protocol, Via Radiology, cancer detection, dense breasts, women's health

February 7, 2017 — A newly developed breast magnetic resonance imaging (MRI) exam protocol, the first of its kind being offered in the Pacific Northwest, is now being performed at Via Radiology in north Seattle.

Fifty percent of women over the age of 40 have dense breast tissue, which significantly reduces the ability to detect cancer on mammograms. MRI is a powerful tool in its ability to detect early breast cancer and is not affected by dense breast tissue. However, due to its high cost, breast MRI has until now only been recommended for screening women who are at high risk.

Via Radiology’s Abbreviated Breast MRI (AB-MR) protocol distills traditional breast MRI to its essential components that can then be performed more quickly and affordably compared with traditional breast MRI. Studies have shown that this new protocol is equivalent in accuracy to the traditional exam.

On average, mammograms detect four to five cancers per 1,000 women screened, whereas breast MRI detects 16-23 more cancers per 1,000 women screened, according to Via Radiology CEO Craig Hanson, M.D. He added that the lower end of that range comes in women who are at average risk of getting breast cancer.

The sensitivity of mammography in dense-breasted women is only 38 percent, meaning up to 62 percent of cancers may go undetected until they are discovered as a palpable lump. As a result, there is an excess of late-stage disease and mortality in these women.

Hanson added that breast ultrasound only detects two to three more cancers per 1,000 average-risked women screened, and at the cost of a high false positive rate, meaning lots of unnecessary biopsies.

While there have been major advances in breast cancer treatment, the stage at the time of diagnosis remains the most important factor in survival. Finding a breast cancer early also means less debilitating and costly treatment.

At less than $500, AB-MR now provides a viable, highly accurate alternative method for screening women at any risk, especially those with dense breast tissue.

For more information: www.viaradiology.com

Related Content

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
Fujifilm Announces Nationwide Breast Health Campaign With Mobile Mammography Coach

At the center of the campaign, Fujifilm will be traveling around the U.S. with its "Aspire to Be Fearless" mobile mammography coach to provide educational opportunities for clinicians, raise awareness about the importance of screening and will be providing mammograms to the underserved population in key locations.

News | Mammography | June 14, 2019
Fujifilm Medical Systems U.S.A. Inc. announced a nationwide awareness campaign titled ‘Aspire to Be Fearless’ focused...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA
News | Mammography Reporting Software | June 13, 2019
Ikonopedia will showcase its suite of structured breast reporting and Mammography Quality Standards Act (MQSA)...
iCAD Introduces ProFound AI for 2D Mammography in Europe
News | Artificial Intelligence | June 13, 2019
iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to...
Three Palm Software Releases WorkstationOne Version 1.8.8
Technology | Mammography Reporting Software | June 12, 2019
Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...